HIPAA Handbooks

  • Privacy and security training for new and seasoned staff
  • 11 staff/setting focus areas
  • Education on protecting PHI
  • HITECH Act updates
  • Discounts on bulk purchases

More»

E-learning

  • Role-based training using real-life case scenarios
  • Test-your-knowledge exercises with remediation
  • Post-course test to document staff participation

More»

Other HIPAA Resources

  • Hot-topic audio conferences
  • CD-Rom, books on privacy and security
  • Business associate training
  • Videos with real-life HIPAA scenarios

More»

Nov
02

HIPAA Q&A: Anticoagulation clinics

Email This Post Print This Post

Q. An anticoagulation clinic might offer group classes for newly enrolled patients. The classes would include the effects of the patient’s diet and over-the-counter medications, the effects of prescription medication on anticoagulation medication dosing, safety measures, review of conditions requiring anticoagulation medication, and potential complications and side effects of anticoagulation therapy.

If we don’t discuss specific individual information in the group setting, are we still at risk for a potential HIPAA violation?

A. As long as you inform the newly enrolled patients in advance that other patients requiring anticoagulation therapy will attend voluntarily, you will not be in violation of the HIPAA privacy rule. Mandatory attendance could represent a HIPAA privacy rule violation because you would be exposing patients to other patients with similar conditions. Patients’ voluntary attendance indicates to others present that they or their family members take anticoagulation medication.

Editor’s note: Chris Apgar, CISSP, answered this question. This is not legal advice. Consult your attorney regarding legal matters.

Leave a Reply